Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2010
08/31/2010US7786113 Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
08/31/2010US7786112 Small molecule antiproliferative agents
08/31/2010US7786110 Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
08/31/2010US7786108 Compounds and method for treating dyslipidemia
08/31/2010US7786105 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease
08/31/2010US7786045 fungicide, insecticide and miticide; 3-(4-chlorophenyl)-1-methyl-1H-pyrazol-5 oxy derivatives
08/31/2010CA2569861C Pyrrolidine derivatives as ccr5 antagonists
08/31/2010CA2389545C Chemokine receptor binding heterocyclic compounds
08/26/2010WO2010096371A2 Heterocyclic compounds which modulate the cb2 receptor
08/26/2010WO2010096314A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS
08/26/2010WO2010096302A1 Hepatitis c virus inhibitors
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010WO2010095602A1 Heterocyclic compound
08/26/2010WO2010095462A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
08/26/2010WO2010094755A1 Carboxamide compounds and their use as calpain inhibitors
08/26/2010WO2010094669A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
08/26/2010WO2010094647A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/26/2010WO2010094645A1 Substituted pyridine derivatives and their medical use
08/26/2010WO2010094126A1 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/26/2010WO2010019772A3 Oxadiazole-2-oxides as antischistosomal agents
08/26/2010WO2009151495A3 Oxazole compounds, compositions and methods of use
08/26/2010WO2007039781A3 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors
08/26/2010US20100217008 Process for the preparation of valsartan and intermediate products
08/26/2010US20100216853 Methods and Compositions for Modulating P300/CBP Activity
08/26/2010US20100216851 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
08/26/2010US20100216850 Insecticidal compounds
08/26/2010US20100216845 Isoxazoles / o-pyridines with ethyl and ethenyl linker
08/26/2010US20100216841 4-Fluoro-Piperidine T-Type Calcium Channel Antagonists
08/26/2010US20100216840 Benzimidazolidinone derivatives as muscarinic agents
08/26/2010US20100216833 Tetrahydrocarbazoles and derivatives
08/26/2010US20100216823 Spirocyclic Derivatives
08/26/2010US20100216821 Benzimidazoles With A Hetero Spiro-Decane Residue As NPY-Y5 Antagonists
08/26/2010US20100216816 Pyrazinyl amide-t type calcium channel antagonists
08/26/2010US20100216809 Piperidine/piperazine derivatives
08/26/2010US20100216795 Tnik inhibitor and the use
08/26/2010US20100216793 Heteroaryl substituted pyridazinone derivatives
08/26/2010US20100216792 Pesticidal arylpyrrolidines
08/26/2010US20100216791 Pyridinylquinazolinamine derivatives and their use as b-raf inhibitors
08/26/2010US20100216788 Fused heterocyclic compound
08/26/2010US20100216786 New compounds
08/26/2010US20100216783 Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
08/26/2010US20100216772 Novel Phenantridine Analogues and Uses Thereof
08/26/2010US20100216769 Substituted glycinamides, process for their manufacture and use thereof as medicaments
08/26/2010US20100216767 Quinazolines for pdk1 inhibition
08/26/2010US20100216763 Heteroaryl Amide Derivatives
08/26/2010US20100216750 Tricyclic inhibitors of fatty acid amide hydrolase
08/26/2010US20100216748 Pyrrole Derivatives and Their Methods of Use
08/26/2010US20100216746 Chemical compounds
08/26/2010US20100216726 Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof
08/26/2010US20100216665 Detection of immobilized nucleic acid
08/26/2010US20100215618 Novel compounds - 644
08/26/2010US20100215616 Hepatitis C Virus Inhibitors
08/26/2010CA2752579A1 Hepatitis c virus inhibitors
08/26/2010CA2750993A1 Carboxamide compounds and their use as calpain inhibitors
08/26/2010CA2750635A1 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/26/2010CA2749649A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
08/26/2010CA2749495A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/25/2010EP2221305A1 Method for synthesizing intermediate compound for synthesizing a pharmaceutical agent
08/25/2010EP2221304A1 Method for synthesizing intermediate compound for synthesizing a pharmaceutical agent
08/25/2010EP2221303A1 Benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode
08/25/2010EP2221302A1 Pyrido-oxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode
08/25/2010EP2221298A1 Phenylpyrazole derivatives
08/25/2010EP2220079A2 Substituted amides, manufacturing and use thereof as medicaments
08/25/2010EP2220078A2 Benzomorpholine derivatives and methods of use
08/25/2010EP2220077A1 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases
08/25/2010EP2220076A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220068A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
08/25/2010EP2220059A1 2-aminooxazole derivatives as trpvl antagonists useful for treating pain
08/25/2010EP2220048A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/25/2010EP2220046A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2219629A1 Novel compounds as cannabinoid receptor ligands
08/25/2010EP1994030B1 Multi-cyclic compounds and method of use
08/25/2010EP1910338B1 Heterotetracyclic compounds as tpo mimetics
08/25/2010EP1879884B1 Azole-based phosphodiesterase inhibitors
08/25/2010EP1871758B1 Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
08/25/2010EP1778676B1 Hydantoin derivatives for the treatment of inflammatory disorders
08/25/2010EP1742912B1 Novel androgens
08/25/2010EP1737844B1 Bicyclic anthranilamide derivatives useful as insecticides
08/25/2010EP1591443B1 Pyrazole derivative
08/25/2010EP1363632B1 Receptor selective cannabimimetic aminoalkylindoles
08/25/2010EP1325920B1 N-substituted benzothiophenesulfonamide derivatives
08/25/2010EP1133294B1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
08/25/2010CN101815711A Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
08/25/2010CN101815710A Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
08/25/2010CN101815706A isoxazoline insecticides
08/25/2010CN101812059A Nitric oxide donor-type farnesyl thiosalicylic acid derivative, and preparation method and medical application thereof
08/25/2010CN101812058A Indometacin 2-arylmorpholine ethyl, preparation method and application thereof
08/25/2010CN101812057A Oxadiazole derivative, and light-emitting element and light-emitting device using oxadiazole derivative
08/25/2010CN101812056A A novel pyridine derivative substituted by alkyl acting as an reuptaking inhibitor for the monoamine neurotransmitter.
08/25/2010CN101812055A Compound and method applying same for fluorescence detection of activity of monoamine oxidase
08/25/2010CN101265255B Method for preparing benzoxazine intermediate containing triazine structure
08/24/2010US7781595 Benzimidazole derivatives: preparation and pharmaceutical applications
08/24/2010US7781579 Cyclopentaphenanthrene-based compound and organic electroluminescent device using the same
08/24/2010US7781460 isoxazoline indazoles derivatives, such as 3-(1-Cyclopentyl-1H-indazol-6-yl)-5-methyl-4,5-dihydroisoxazole-5-carbonitrile, useful in the treatment of nervous system, respiratory system and skin disoders, AIDS, shock,, Crohn's disease, granuloma, vision defects and inflammatory diseases
08/24/2010US7781456 The desired characteristics of chiral compounds helps reduce the toxicity of compound; to treat mood disorders, depression; pain, neurodegenerative disorders, sexual disorders, drug abuse etc.
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010US7781442 N-phenyl-1,3-thiazol-2-amine derivatives, useful in the treatment of neurodegenerative disorders, such as Alzheimer's disease
08/24/2010US7781435 (S)-2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoic acid {1-[2-(3-ethoxy-propylamino) -ethyl]-1H-imidazol-4-yl}-amide, having beta-amyloid peptide production inhibitory activity, used for the treatment of neurodegenerative disorders such as Alzheimer's disease
08/24/2010US7781434 7-Chloro-2-isopropyl-5-[3-(morpholine-4-carbonyl)-isoxazol-5-yl]-2,3-dihydro-isoindol-1-one; drug targets in the therapy of acute and chronic neurological and psychiatric disorders and chronic and acute pain disorders; schizophrenia or anxiety; Sandmeyer reaction of a 4-bromoaniline
08/24/2010US7781433 Pharmaceutical compounds
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 647